Trinity Biotech plc
TRIB
Price:
$1.4199
Market Cap:
$17.21M
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identify...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1992-10-21
Stock Exchange
NASDAQ
Ticker
TRIB
The ROE as of September 2024 (TTM) for Trinity Biotech plc (TRIB) is 95.19%
According to Trinity Biotech plc’s latest financial reports and current stock price. The company's current ROE is 95.19%. This represents a change of 284.99% compared to the average of 24.73% of the last 4 quarters.
Trinity Biotech plc (TRIB) Historical ROE (quarterly & annually)
How has TRIB ROE performed in the past?
The mean historical ROE of Trinity Biotech plc over the last ten years is 176.50%. The current 95.19% ROE has changed -46.07% with respect to the historical average. Over the past ten years (40 quarters), TRIB's ROE was at its highest in in the December 2022 quarter at 463.05%. The ROE was at its lowest in in the March 2021 quarter at -1261.42%.
Average
176.50%
Median
7.08%
Minimum
-274.29%
Maximum
1.88%
Trinity Biotech plc (TRIB) ROE by Quarter and Year
Discovering the peaks and valleys of Trinity Biotech plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.71%
Maximum Annual ROE = 1.88%
Minimum Annual Increase = -1690.22%
Minimum Annual ROE = -274.29%
| Year | ROE | Change |
|---|---|---|
| 2023 | 100.29% | -94.68% |
| 2022 | 1.88% | -786.96% |
| 2021 | -274.29% | -201.22% |
| 2020 | 270.98% | -414.10% |
| 2019 | -86.27% | -1690.22% |
| 2018 | 5.43% | -108.78% |
| 2017 | -61.77% | -33.26% |
| 2016 | -92.55% | -1008.20% |
| 2015 | 10.19% | 16.61% |
| 2014 | 8.74% | 54.71% |
Trinity Biotech plc (TRIB) Average ROE
How has TRIB ROE performed in the past?
The current ROE of Trinity Biotech plc (TRIB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
570.09%
5-year avg
379.00%
10-year avg
176.50%
Trinity Biotech plc (TRIB) ROE vs. Peers
How is TRIB’s ROE compared to its peers?
Trinity Biotech plc’s ROE is greater than Star Equity Holdings, Inc. (-11.03%), greater than Standard BioTools Inc. (-42.41%), greater than Genetron Holdings Limited (-36.51%), greater than Biodesix, Inc. (-525.32%), greater than ENDRA Life Sciences Inc. (-162.48%), greater than Sera Prognostics, Inc. (-46.71%), greater than Olink Holding AB (publ) (-7.07%), less than FONAR Corporation (9.60%), greater than Neuronetics, Inc. (-109.00%), greater than Exagen Inc. (-78.90%), less than Sotera Health Company (9.59%), greater than Aclaris Therapeutics, Inc. (-39.83%), greater than Castle Biosciences, Inc. (-0.77%), greater than Prenetics Global Limited (-29.80%), greater than MDxHealth SA (-1069.08%), greater than Inotiv, Inc. (-43.49%),
| Company | ROE | Market cap |
|---|---|---|
| -11.03% | $13.13M | |
| -42.41% | $781.28M | |
| -36.51% | $127.29M | |
| -525.32% | $260.59M | |
| -162.48% | $4.25M | |
| -46.71% | $264.23M | |
| -7.07% | $3.24B | |
| 9.60% | $110.81M | |
| -109.00% | $28.14M | |
| -78.90% | $48.86M | |
| 9.59% | $4.75B | |
| -39.83% | $85.61M | |
| -0.77% | $861.37M | |
| -29.80% | $53.69M | |
| -1069.08% | $72.31M | |
| -43.49% | $45.77M |
Build a custom stock screener for Trinity Biotech plc (TRIB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trinity Biotech plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Trinity Biotech plc (TRIB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Trinity Biotech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Trinity Biotech plc's ROE?
How is the ROE calculated for Trinity Biotech plc (TRIB)?
What is the highest ROE for Trinity Biotech plc (TRIB)?
What is the 3-year average ROE for Trinity Biotech plc (TRIB)?
What is the 5-year average ROE for Trinity Biotech plc (TRIB)?
How does the current ROE for Trinity Biotech plc (TRIB) compare to its historical average?